StreetAlpha.app
Home › Stocks › TEVA

Teva Pharmaceutical Industries Ltd (TEVA)

Healthcare
$42.61
▲ +0.09%
LAST CLOSE · NOV 17

Teva makes generic, biosimilar and branded medicines for patients, pharmacies and healthcare providers. It last closed at $42.61 on Nov 17, up 0.09% on the day. TEVA reports earnings on Wed, Jan 27, 2027. The average 12-month price target from 9 analysts is $51.56 (+21.0% from the last close), with a high of $57.00 and a low of $47.00. Analyst consensus is Strong Buy, based on the latest ratings from 9 firms (9 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 2 whale options trades in TEVA, 50% of them bullish and 50% bearish. In the past 30 days there were 7 dark pool prints totaling $28.1M, the largest $21.1M.

AI Auto Pilots
Is TEVA in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$17.2B
+2.7% vs a year ago
Net income
$506.0M
−29.0% vs a year ago
EPS (diluted)
$0.43
−29.5% vs a year ago
Free cash flow
$1.2B
7.2% margin
Valuation
Market cap
$49.7B
1.17B shares
P/E
99.1
Price over 12 month EPS
Price to sales
2.9
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$4.1B
At Sep 30
Shareholder equity
$8.0B
Shares outstanding
1.17B
At Sep 30
CEORichard Francis
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $15.9B$15.9BFY2021FY2022: $14.9B$14.9BFY2022FY2023: $15.8B$15.8BFY2023FY2024: $16.5B$16.5BFY2024FY2025: $17.3B$17.3BFY2025

From TEVA's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 3). Last 12 months adds up the four latest quarters.

Next report
Jan 27
2027 · Time not announced
Consensus EPS forecast
$0.70
$4.27B revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
Strong Buy
Based on 9 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
9firms
9 Buy0 Hold0 Sell
Each firm's latest rating on TEVA in the past 90 days
Average 12-month target
$51.56
▲ 21.0% upside

Based on 9 analysts who set a price target on TEVA in the past 90 days. The average target is $51.56, with a high of $57.00 and a low of $47.00, compared with the last close of $42.61.

$29$39$49$59PAST 59 TRADING DAYS12-MONTH TARGETSHIGH $57AVG $51.56LOW $47May 22LAST CLOSE+12 MO$29$39$49$59PAST 59 DAYSTARGETSHIGH $57AVG $51.56LOW $47May 22LAST CLOSE+12 MO
Highest target$57.00
Average target$51.56
Lowest target$47.00
Latest rating changes
Argus ResearchMaintained
Nov 17Buy$50
HC Wainwright & Co.Reiterated
Nov 17Buy$54
Piper SandlerTarget raised
Nov 12Buy$44 → $56
Leerink PartnersTarget raised
Nov 5Buy$45 → $52
TD CowenTarget raised
Nov 4Buy$55 → $57
DateFirmActionRatingPrice target
Nov 17Argus ResearchMaintainedBuy$50
Nov 17HC Wainwright & Co.ReiteratedBuy$54
Nov 12Piper SandlerTarget raisedBuy$44 → $56
Nov 5Leerink PartnersTarget raisedBuy$45 → $52
Nov 4TD CowenTarget raisedBuy$55 → $57
Loading…

Technical Analysis

TEVA · as of the Nov 17 close · updated after every close
Uptrend

The stock is 2% above its 20 day and 5% above its 50 day average. It is 17% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 56). The nearest support is the Pivot at $42.29, and the nearest resistance the Pivot R1 at $43.01.

Short trendBullish
Long trendBullish
MomentumStrong
StretchNormal
VolatilityNormal, 3.0%/day
Key levels
$44.5752 week high+4.6%
$43.34Swing high (Nov 3)+1.7%
$43.01Pivot R1+0.9%
$42.61Last close
$42.29Pivot−0.8%
$41.88Pivot S1−1.7%
$41.7420 day average−2.0%
$40.4250 day average−5.1%
$39.10Swing low (Oct 23)−8.2%
$37.55100 day average−11.9%
$35.18200 day average−17.4%
$24.0152 week low−43.7%
Indicators
RSI (14)55.66Middle of its rangeNeutral
MACD0.87Above its signal lineBullish
Stochastic72.2Middle of its rangeNeutral
ADX (14)22.9Weak trend
Williams %R-43.0Oversold below −80, overbought above −20Neutral
CCI (20)35.4Oversold below −100, overbought above 100Neutral
Rate of change+1.7%Change over 10 sessionsBullish
ATR (14)$1.26Typical daily range, 3.0% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for TEVA

What happened before

See how TEVA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow TEVA usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How TEVA has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
2
Bullish
1
50%
Bearish
1
50%
Date span
Oct 15 – Nov 12
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
7
Notional
$28.1M
Largest print
$21.1M
Loading…

TEVA Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲574 buying vs 0 selling
  • ▲Held by funds +49.4 pts
  • ▲Funds holding +580
  • ▲Superinvestors: 5 added, 0 cut
  • ●Put/call not meaningful
Q2 '25Q3 '25Q4 '25Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding5811+58000.0%
In funds' top 10190–
Held by funds49.4%0.0%+49.4 pts
New / increased574 / 01 / 0+57300.0%
Reduced / sold out0 / 00 / 0–
Put/call ratio0.65––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See TEVA institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TEVA is in one of them and how their past TEVA trades turned out.

TEVA in the AI portfolios
Loading…

TEVA News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered TEVA in an article yet. Here's the latest on the wider market.

TEVA Congress Trades

All congress trades →
Trades, 12 months
1
Buys
1
100%
Sells
0
0%
People
1
Last filed Jul 21
Who traded TEVA · since 2016
Latest 5 filings
$1K – $15KTraded Mar 30, 2026Filed Jul 21, 2026
$15K – $50KTraded Nov 13, 2020Filed Dec 2, 2020
$1K – $15KTraded May 7, 2020Filed May 15, 2020
$1K – $15KTraded Jun 19, 2019Filed Jul 11, 2019
$1K – $15KTraded Oct 19, 2016Filed Nov 10, 2016
PersonTypeAmountTradedFiledDelay
Alan ArmstrongHouseBuy$1K – $15KMar 30, 2026Jul 21, 2026113 d
Greg GianforteR · MTBuy$15K – $50KNov 13, 2020Dec 2, 202019 d
Donna ShalalaD · FLSell$1K – $15KMay 7, 2020May 15, 20208 d
David E. PriceD · NCSell$1K – $15KJun 19, 2019Jul 11, 201922 d
Angus KingI · MESell$1K – $15KOct 19, 2016Nov 10, 201622 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Teva Pharmaceutical Industries

Teva is a pharmaceutical company based in Tel Aviv. It makes generic medicines, biosimilars that copy complex biologic drugs, and branded medicines for conditions such as movement disorders, migraine and schizophrenia. Its customers include pharmacies, hospitals, physicians, patients and third-party payers such as health insurers. Its products are sold in markets around the world.

Headquarters
Tel Aviv
Founded
1901